Company profile ACHL

Achilles Therapeutics Plc
achilles therapeutics’ mission is to develop next-generation, patient-specific therapies that harness the immune system to destroy cancer cells. the therapies will target truncal (also known as clonal) tumour neo-antigens, unique flags to the immune system present on the surface of every cancer cell. these truncal neo-antigens are created early in the cancer’s evolution and... present on all cancer cells in an individual patient’s tumour but not on healthy cells, so could allow scientists to target and destroy tumours without harming healthy tissues. achilles therapeutics brings together four scientific founders with world leading expertise in the understanding of cancer evolution, bioinformatics and the development of immunotherapies. Show More
Quarter analysis & expected interestLast update: February 08 2024 13:43:03.

After 39 days of this quarter the interest is at 127.0. Based on that we can calculate that during remaining 52 days it will total up to 296.0.
Achilles Therapeutics expected interest is significantly higher compared to previous quarter (+1457.9%) and same quarter last year (+1038.5%).

YearQ1Q2Q3Q4
201973
47
-35.6% QoQ
8
-83.0% QoQ
64
700.0% QoQ
2020 16
-78.1% YoY -75.0% QoQ
26
-44.7% YoY 62.5% QoQ
34
325.0% YoY 30.8% QoQ
42
-34.4% YoY 23.5% QoQ
2021 111
593.8% YoY 164.3% QoQ
107
311.5% YoY -3.6% QoQ
88
158.8% YoY -17.8% QoQ
56
33.3% YoY -36.4% QoQ
2022 80
-27.9% YoY 42.9% QoQ
86
-19.6% YoY 7.5% QoQ
43
-51.1% YoY -50.0% QoQ
27
-51.8% YoY -37.2% QoQ
2023 26
-67.5% YoY -3.7% QoQ
7
-91.9% YoY -73.1% QoQ
67
55.8% YoY 857.1% QoQ
19
-29.6% YoY -71.6% QoQ
2024 127
388.5% YoY 568.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Achilles Therapeutics search interestLast update: February 08 2024 13:43:02.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 13:43:04.

The average 5 years interest of Achilles Therapeutics was 4.42 per week.
The last year interest of Achilles Therapeutics compared to the last 5 years has changed by 4.07%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by 15.0%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Achilles Therapeutics T cell therapies to provide analysis

Correlation between past revenue and Achilles Therapeutics T cell therapies search interest

There is not enough data for Achilles Therapeutics T cell therapies to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Achilles Therapeutics T cell therapies to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Achilles immuno-oncology to provide analysis

Correlation between past revenue and Achilles immuno-oncology search interest

There is not enough data for Achilles immuno-oncology to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Achilles immuno-oncology to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Achilles Therapeutics careers to provide analysis

Correlation between past revenue and Achilles Therapeutics careers search interest

There is not enough data for Achilles Therapeutics careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Achilles Therapeutics careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Achilles Therapeutics trials to provide analysis

Correlation between past revenue and Achilles Therapeutics trials search interest

There is not enough data for Achilles Therapeutics trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Achilles Therapeutics trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Achilles Therapeutics CHIRON to provide analysis

Correlation between past revenue and Achilles Therapeutics CHIRON search interest

There is not enough data for Achilles Therapeutics CHIRON to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Achilles Therapeutics CHIRON to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Achilles Therapeutics THETIS to provide analysis

Correlation between past revenue and Achilles Therapeutics THETIS search interest

There is not enough data for Achilles Therapeutics THETIS to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Achilles Therapeutics THETIS to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Achilles Therapeutics -stock -company to provide analysis

Correlation between past revenue and Achilles Therapeutics -stock -company search interest

There is not enough data for Achilles Therapeutics -stock -company to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Achilles Therapeutics -stock -company to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for ACHL
Earnings date: 2024-03-05 After close
Company name: Achilles Therapeutics Plc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2025-03-21T09:41:03-04:00

SEC
15-12G Form - Securities registration termination [Section 12(g)] - Achilles Therapeutics plc (0001830749) (Filer)

2025-03-20T17:30:00-04:00

SEC
6-K Form - Report of foreign issuer [Rules 13a-16 and 15d-16] - Achilles Therapeutics plc (0001830749) (Filer)

2025-03-19T16:16:04-04:00

SEC
S-8 POS Form - Securities to be offered to employees in employee benefit plans, post-effective amendments - Achilles Therapeutics plc (0001830749) (Filer)

2025-03-19T16:13:49-04:00

SEC
S-8 POS Form - Securities to be offered to employees in employee benefit plans, post-effective amendments - Achilles Therapeutics plc (0001830749) (Filer)

2025-03-19T16:11:15-04:00

SEC
S-8 POS Form - Securities to be offered to employees in employee benefit plans, post-effective amendments - Achilles Therapeutics plc (0001830749) (Filer)

2025-03-19T16:09:12-04:00

SEC
S-8 POS Form - Securities to be offered to employees in employee benefit plans, post-effective amendments - Achilles Therapeutics plc (0001830749) (Filer)

2025-03-12T00:15:09-04:00

SEC
EFFECT Form - Notice of Effectiveness - Achilles Therapeutics plc (0001830749) (Filer)

2025-03-11T07:15:08-04:00

SEC
POS AM Form - Post-Effective amendments for registration statement - Achilles Therapeutics plc (0001830749) (Filer)

2025-03-11T07:00:08-04:00

SEC
25 Form - Notification of the removal from listing and registration of matured, redeemed or retired securities - Achilles Therapeutics plc (0001830749) (Filer)

2025-03-03T09:52:11-05:00

SEC
144 Form - Report of proposed sale of securities - Achilles Therapeutics plc (0001830749) (Subject)

2025-03-03T09:43:40-05:00

SEC
144 Form - Report of proposed sale of securities - Achilles Therapeutics plc (0001830749) (Subject)

2025-02-28T08:16:47-05:00

SEC
6-K Form - Report of foreign issuer [Rules 13a-16 and 15d-16] - Achilles Therapeutics plc (0001830749) (Filer)

2025-02-28T12:00:00Z

GlobeNewswire
Achilles Therapeutics Announces Voluntary Nasdaq Delisting and SEC Deregistration

2025-02-18T06:37:47-05:00

SEC
144 Form - Report of proposed sale of securities - Achilles Therapeutics plc (0001830749) (Subject)

2025-02-13T17:02:36-05:00

SEC
SCHEDULE 13G/A Form - [Amend] Statement of Beneficial Ownership by Certain Investors - Achilles Therapeutics plc (0001830749) (Subject)